Related Experiment Video
Updated: Apr 7, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Protective effect of probiotics in the treatment of infantile eczema
Rong-Jun Lin1, Li-Hua Qiu2, Ren-Zheng Guan1
1Department of Pediatrics, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266071, P.R. China.
Insights
Probiotic supplementation with Bifidobacterium bifidum effectively reduced eczema severity in infants. This study shows probiotics can help manage infantile eczema by improving gut bacteria and lowering the Scoring Atopic Dermatitis index.
Area of Science:
- Microbiology
- Pediatric Dermatology
- Gastroenterology
Background:
- Infantile eczema is a common condition with complex causes.
- Gut microbiota alterations are implicated in atopic dermatitis.
- Probiotics may modulate the immune response and gut environment.
Purpose of the Study:
- To investigate the efficacy of Bifidobacterium bifidum in treating infantile eczema.
- To assess changes in intestinal Bifidobacteria levels and SCORAD index.
- To provide evidence for probiotic application in eczema prevention and treatment.
Main Methods:
- Randomized controlled trial with 40 infants diagnosed with eczema.
- Treatment group received B. bifidum capsules; control group received placebo.
- Quantification of B. bifidum in stool using 16S rRNA/DNA qPCR.
- Evaluation of Scoring Atopic Dermatitis (SCORAD) index before and after 4 weeks of treatment.
Main Results:
- B. bifidum levels significantly increased in the treatment group (P<0.05).
- SCORAD index significantly decreased in the treatment group (P<0.05).
- No significant changes in B. bifidum or SCORAD index were observed in the control group.
- Post-treatment B. bifidum levels were higher and SCORAD index lower in the treatment group compared to controls (P<0.05).
Conclusions:
- Probiotic supplementation with B. bifidum demonstrates a positive effect on infantile eczema.
- B. bifidum may be beneficial in both preventing and treating infantile eczema.
- Modulating gut microbiota with probiotics offers a potential therapeutic strategy for eczema.
Abstract:
The aim of the present study was to provide evidence for the application of probiotics in the prevention and treatment of infantile eczema by exploring changes in the intestinal Bifidobacteria levels and the Scoring Atopic Dermatitis (SCORAD) index prior and subsequent to treatment with probiotics in infants with eczema. A total of 40 infants with eczema were randomly divided into treatment and control groups. Prior and subsequent to the treatment, the SCORAD index was evaluated and the content of Bifidobacterium bifidum in the stool of each infant in the two groups was quantified using 16S rRNA/DNA quantitative polymerase chain reaction analysis. After four weeks of treatment with B. bifidum triple viable capsules, the levels of B. bifidum increased sharply (P<0.05) and the SCORAD index was notably reduced (P<0.05) as compared with the values prior to treatment. By contrast, neither the content of B. bifidum nor the SCORAD index changed significantly in the control group after four weeks (P>0.05). Following treatment, the levels of B. bifidum in the stools of the treatment group were significantly higher than those in the stools of the control group (P<0.05), and the SCORAD index was significantly lower than that of the control group (P<0.05). In conclusion, probiotic supplementation has a positive effect on the prevention and treatment of infantile eczema.
More Related Videos
Related Concept Videos
Probiotics
Development of Human Microbiota
Acne Infection
Development of the Oral Microbiota
The Skin Microbiota
Defense Mechanism Against Infection
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...

